Park Dental Partners, Inc. (PARK) AI Stock Analysis
PARK AI stock analysis summary
AI ResearchPark Dental Partners, Inc. (PARK) provides administrative support services to dental practices across Minnesota, Wisconsin, and Arizona. In FY2025, annual revenue reached $244.5M, while net income contracted to -$358,000. Over the trailing twelve months, revenue totaled $251.4M with a profit margin of -1.4%.
- Market cap
- $90.1M
- Revenue (TTM)
- $251.4M
- P/E
- —
- 1Y return
- — S&P 500 16.8%
- Avg. target
- $28.50 50.4% vs last close
Bull case
- Revenue grew at a 4.6% CAGR from FY2023 to FY2025, reaching $244.5M.
- Analysts maintain a mean price target of $28.50, representing 50.4% upside over the last close.
- The company generated $10.3M in free cash flow and $17.6M in operating cash flow in FY2025.
Bear case
- Net income fell from $4.4M in FY2024 to -$358,000 in FY2025.
- Quarterly earnings dropped 84.8% year-over-year in the quarter ended June 30, 2026.
- Trailing twelve month return on equity is -24.2% while the EV-to-EBITDA multiple is 54.3x.
What Park Dental Partners does
Park Dental Partners, Inc. operates as a dental resource organization that provides administrative business support services to dentists in Minnesota, Wisconsin, and Arizona. The company offers general and specialty dental care services, such as dentist and hygiene, oral surgery, periodontics, pediatric dentistry, prosthodontics, endodontics, and orthodontics. It supplies clinical team members, administrative personnel, and facilities and equipment to its affiliated general and multi-specialty dental practices. Founded in 1972, the company is headquartered in Roseville, Minnesota and employs 1,212 people.
Growth and profitability
Revenue increased from $223.5M in FY2023 to $229.8M in FY2024, growing 2.8%, and reached $244.5M in FY2025, reflecting 6.4% growth and a 2-year CAGR of 4.6%. Gross margin rose from 12.2% in FY2023 to 14.9% in FY2024 before settling at 13.2% in FY2025. Operating margin shifted from 1.0% in FY2023 to 3.8% in FY2024 and 1.2% in FY2025. Net income went from $4.9M in FY2023 to $4.4M in FY2024, before declining to -$358,000 in FY2025 with a net margin of -0.1%. For the latest quarter ended June 30, 2026, quarterly revenue grew 5.1% year-over-year, while quarterly earnings fell 84.8%.
Balance sheet and cash flow
As of June 30, 2026, the company held $24.40B in cash and short-term investments against total debt of $60.1M, yielding net cash of $24.34B. Shareholders' equity was $29.8M out of total assets of $186.3M. The company reported a current ratio of 1.12 and a debt-to-equity ratio of 2.02. During FY2025, operating cash flow reached $17.6M and free cash flow was $10.3M. Capital deployment in FY2025 included $7.3M for capital expenditures, $704,000 for share buybacks, and $704.0M in dividends paid.
Valuation and performance
With a market capitalization of $90.1M and an enterprise value of $131.7M, PARK trades at a price-to-sales multiple of 0.4x and an enterprise-value-to-revenue multiple of 0.5x, below the median of 4.1x price-to-sales for its US-listed Healthcare peers. Its EV-to-EBITDA multiple stands at 54.3x, compared to the peer median of 12.0x. The company has a price-to-book ratio of 3.2x. Year to date, the stock has returned 28.4% through October 16, 2026, trading 1.2% above its 200-day moving average.
What analysts expect
Wall Street coverage includes 2 Strong Buy ratings with no Buy, Hold, Sell, or Strong Sell ratings. The mean price target is $28.50, representing a 50.4% premium over the last close of $18.95. The company has posted 4 EPS beats over the last 4 quarters. For the fiscal year ending December 31, 2026, analysts estimate revenue of $258.1M and an EPS of $1.66. The company's next earnings date is scheduled for November 11, 2026.
Key risks and what to watch
- The debt-to-equity ratio stands at 2.02 with total debt of $60.1M against shareholders' equity of $29.8M.
- The company's TTM operating margin of 1.9% trails the US-listed Healthcare peer median of 14.0%.
- Current fiscal year consensus estimates project an EPS decline of 32.0% to $1.66.
AI-generated research summary. Written with AI from Quotelinks data as of October 16, 2026 and checked so every figure matches that data. For information only, not investment advice. Disclaimer
About this PARK AI stock analysis
This page is an AI-written research summary of Park Dental Partners, Inc. (PARK). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.
Related: PARK income statement, PARK balance sheet, PARK key metrics, PARK analyst forecast, PARK chart. See the PARK stock overview for the latest quote and news.
PARK AI stock analysis FAQ
What does Park Dental Partners do?
Park Dental Partners, Inc. provides administrative business support services, facilities, equipment, and clinical personnel to dental practices in Minnesota, Wisconsin, and Arizona.
What is the analyst price target for PARK stock?
The mean analyst price target is $28.50, which is 50.4% higher than the last close of $18.95 across 2 Strong Buy ratings.
How did PARK perform in FY2025?
In FY2025, PARK generated revenue of $244.5M, reflecting 6.4% growth, but reported a net income of -$358,000 and free cash flow of $10.3M.
When does PARK report its next earnings?
The company is scheduled to report its next quarterly earnings on November 11, 2026.